Document Control No. 16ICH Guideline Topic S6(R1): preclinical safety evaluation of biotechnology-derived pharmaceuticals. European Medicines Agency (EMA/CHMP/ICH/731268/1998), 2011. 17Nivolumab (BMS- 936558) Investigator Brochure Version 16. Bristol-Myers Squibb Company; 2017. Docume nt Control No. 18Ipilimumab (BMS-734016) Investigator Brochure Version 19. Bristol-Myers Squibb Company; 2016.